These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 11073106

  • 1. Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein.
    Bülow E, Gullberg U, Olsson I.
    J Leukoc Biol; 2000 Nov; 68(5):669-78. PubMed ID: 11073106
    [Abstract] [Full Text] [Related]

  • 2. Protein fusions of BPI with CETP retain functions inherent to each.
    Lloyd DB, Bonnette P, Thompson JF.
    Biochemistry; 2006 Oct 31; 45(43):12954-9. PubMed ID: 17059212
    [Abstract] [Full Text] [Related]

  • 3. The BPI/LBP family of proteins: a structural analysis of conserved regions.
    Beamer LJ, Carroll SF, Eisenberg D.
    Protein Sci; 1998 Apr 31; 7(4):906-14. PubMed ID: 9568897
    [Abstract] [Full Text] [Related]

  • 4. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
    Dentener MA, Von Asmuth EJ, Francot GJ, Marra MN, Buurman WA.
    J Immunol; 1993 Oct 15; 151(8):4258-65. PubMed ID: 8409400
    [Abstract] [Full Text] [Related]

  • 5. The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved.
    Hubacek JA, Büchler C, Aslanidis C, Schmitz G.
    Biochem Biophys Res Commun; 1997 Jul 18; 236(2):427-30. PubMed ID: 9240454
    [Abstract] [Full Text] [Related]

  • 6. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
    Schumann RR, Lamping N, Hoess A.
    J Immunol; 1997 Dec 01; 159(11):5599-605. PubMed ID: 9548502
    [Abstract] [Full Text] [Related]

  • 7. Identification and expression analysis on bactericidal permeability-increasing protein (BPI)/lipopolysaccharide-binding protein (LBP) of ark shell, Scapharca broughtonii.
    Mao Y, Zhou C, Zhu L, Huang Y, Yan T, Fang J, Zhu W.
    Fish Shellfish Immunol; 2013 Sep 01; 35(3):642-52. PubMed ID: 23742867
    [Abstract] [Full Text] [Related]

  • 8. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.
    Schindler R, Marra MN, McKelligon BM, Lonnemann G, Schulzeck P, Schulze M, Oppermann M, Shaldon S.
    Clin Nephrol; 1993 Dec 01; 40(6):346-51. PubMed ID: 7507806
    [Abstract] [Full Text] [Related]

  • 9. Molecular cloning and characterization of LPS-binding protein/bactericidal permeability-increasing protein (LBP/BPI) from olive flounder, Paralichthys olivaceus.
    Nam BH, Ahn KJ, Kim YO, Kong HJ, Kim WJ, Kim HS, Lee SJ, Kim KK.
    Vet Immunol Immunopathol; 2010 Feb 15; 133(2-4):256-63. PubMed ID: 19698997
    [Abstract] [Full Text] [Related]

  • 10. All-trans retinoic acid-induced expression of bactericidal/permeability-increasing protein (BPI) in human myeloid cells correlates to binding of C/EBPbeta and C/EBPepsilon to the BPI promoter.
    Lennartsson A, Vidovic K, Pass MB, Cowland JB, Gullberg U.
    J Leukoc Biol; 2006 Jul 15; 80(1):196-203. PubMed ID: 16684888
    [Abstract] [Full Text] [Related]

  • 11. mRNA expression patterns of the BPI/LBP molecule in the Atlantic cod (Gadus morhua L.).
    Solstad T, Stenvik J, Jørgensen TØ.
    Fish Shellfish Immunol; 2007 Aug 15; 23(2):260-71. PubMed ID: 17442589
    [Abstract] [Full Text] [Related]

  • 12. Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function.
    Capodici C, Weiss J.
    J Immunol; 1996 Jun 15; 156(12):4789-96. PubMed ID: 8648126
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunochemical evidence that cholesteryl ester transfer protein and bactericidal/permeability-increasing protein share a similar tertiary structure.
    Guyard-Dangremont V, Tenekjian V, Chauhan V, Walter S, Roy P, Rassart E, Milne AR.
    Protein Sci; 1999 Nov 15; 8(11):2392-8. PubMed ID: 10595541
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI).
    Azuma M, Matsuo A, Fujimoto Y, Fukase K, Hazeki K, Hazeki O, Matsumoto M, Seya T.
    Biochem Biophys Res Commun; 2007 Mar 09; 354(2):574-8. PubMed ID: 17239348
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A, McKinney CE, Rinaldi M, Zarlenga DS, Bannerman DD.
    Vet Microbiol; 2007 Nov 15; 125(1-2):80-90. PubMed ID: 17560054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.